Growth Metrics

Baxter International (BAX) Current Deferred Revenue (2021 - 2023)

Baxter International (BAX) has disclosed Current Deferred Revenue for 3 consecutive years, with $169.0 million as the latest value for Q4 2023.

  • On a quarterly basis, Current Deferred Revenue fell 2.31% to $169.0 million in Q4 2023 year-over-year; TTM through Dec 2023 was $169.0 million, a 2.31% decrease, with the full-year FY2023 number at $169.0 million, down 2.31% from a year prior.
  • Current Deferred Revenue was $169.0 million for Q4 2023 at Baxter International, down from $173.0 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $196.0 million in Q4 2021 to a low of $169.0 million in Q4 2023.
  • A 3-year average of $179.3 million and a median of $173.0 million in 2022 define the central range for Current Deferred Revenue.
  • Peak YoY movement for Current Deferred Revenue: fell 11.73% in 2022, then fell 2.31% in 2023.
  • Baxter International's Current Deferred Revenue stood at $196.0 million in 2021, then fell by 11.73% to $173.0 million in 2022, then dropped by 2.31% to $169.0 million in 2023.
  • Per Business Quant, the three most recent readings for BAX's Current Deferred Revenue are $169.0 million (Q4 2023), $173.0 million (Q4 2022), and $196.0 million (Q4 2021).